Complex Lemierre syndrome with multisystemic abscesses.
Détails
Télécharger: 37085282_BIB_08831342902A.pdf (828.13 [Ko])
Etat: Public
Version: Final published version
Licence: CC BY-NC 4.0
Etat: Public
Version: Final published version
Licence: CC BY-NC 4.0
ID Serval
serval:BIB_08831342902A
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Etude de cas (case report): rapporte une observation et la commente brièvement.
Collection
Publications
Institution
Titre
Complex Lemierre syndrome with multisystemic abscesses.
Périodique
BMJ case reports
ISSN
1757-790X (Electronic)
ISSN-L
1757-790X
Statut éditorial
Publié
Date de publication
21/04/2023
Peer-reviewed
Oui
Volume
16
Numéro
4
Pages
e254638
Langue
anglais
Notes
Publication types: Case Reports ; Journal Article
Publication Status: epublish
Publication Status: epublish
Résumé
We present here the challenging case of severe Lemierre syndrome in a healthy woman in her late twenties, whose clinical presentation was characterised by lung abscesses and disseminated systemic abscesses in the brain, the abdomen and the soft-tissues, as a likely consequence of a patent foramen ovale. Blood cultures were positive for Fusobacterium necrophorum and a right lingual vein thrombosis was detected at a late stage when the patient developed a septic shock. Initial antimicrobial therapy with metronidazole and ceftriaxone was modified to meropenem due to progressive worsening. The patient underwent laparoscopy and neurosurgical drainage of a cerebral abscess. She spent many days in the intensive care unit and recovered fully after 6 weeks on meropenem therapy. Although considered rare, the incidence of Lemierre syndrome, a potentially life-threatening condition, is increasing. The clinician should promptly recognise and treat it while being aware of its potential atypical presentations.
Mots-clé
Female, Humans, Lemierre Syndrome/diagnosis, Lemierre Syndrome/drug therapy, Lemierre Syndrome/microbiology, Meropenem/therapeutic use, Brain Abscess/diagnostic imaging, Brain Abscess/drug therapy, Ceftriaxone/therapeutic use, Metronidazole/therapeutic use, Fusobacterium necrophorum, Anti-Bacterial Agents/therapeutic use, Fusobacterium Infections/complications, Fusobacterium Infections/diagnosis, Fusobacterium Infections/drug therapy, Ear, nose and throat/otolaryngology, Infectious diseases, Intensive care, Surgery
Pubmed
Web of science
Open Access
Oui
Création de la notice
01/05/2023 9:50
Dernière modification de la notice
09/08/2024 14:55